No Data
Ascentage Pharma Announces Change in Company Secretary
ASCENTAGE-B (06855): Chen Zhuochen has been appointed as the company secretary.
ASCENTAGE-B (06855) announced that Wang Zhangqi has resigned as (i) company secretary; (ii) Hong Kong United Exchange...
Ascent Pharma (06855.HK) exercised the over-allotment option for American Depositary Shares.
Aspen Pharma (06855.HK) announced that the underwriter has exercised the over-allotment option and the settlement related to the over-allotment option took place yesterday (the 13th) Eastern Time in the USA. The company issued 0.9351 million American Depositary Shares at an offering price of 17.25 USD per share (equivalent to approximately 33.57 HKD per share) following the settlement of the over-allotment option, which accounts for about 1.07% of the issued ordinary shares. The total proceeds from the optional American Depositary Shares under the offering is approximately 16.13 million USD (about 0.126 billion HKD), with a net amount of approximately 1.1 million USD (about 8.8 million).
ASCENTAGE-B: Delivery of the exercise of the over-allotment option related to the sale of American Depositary Shares.
ASCENTAGE-B (06855) announced that the underwriter has exercised the over-allotment option and the related delivery of the over-allotment option took place on February 13, 2025 (Eastern Time, USA). The company issued 935,144 American Depositary Shares (representing 3.7406 million related shares according to the representation ratio) at an offering price of $17.25 per share, following the delivery of the over-allotment option, accounting for approximately 1.07% of the total issued common shares. The total proceeds from the optional American Depositary Shares under the offering amount to approximately $16.13 million.
ASCENTAGE-B (06855) issued 3.7406 million shares on February 11 according to the underwriting agreement by exercising the over-allotment option.
ASCENTAGE-B (06855) announced that on February 11, 2025, according to January 23, 2025...
Ehouse Medicine (06855.HK) has exercised excess rights for its U.S. depositary shares, raising an additional 0.14 billion USD.
Ascentage Pharma - B (06855.HK) announced that the overallotment option for the sale of American depositary shares has been partially exercised, involving an additional 935,100 shares at a price of $17.25 per share, with total proceeds of approximately $0.143 billion.
